| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/21/2013 | US20130045488 Benzocyanine compounds |
| 02/21/2013 | US20130045486 Composition for Cancer Prognosis Prediction Comprising Anti-TMAP/CKAP2 Antibodies |
| 02/21/2013 | US20130045480 Novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes - useful or detection or quantification of desirable target molecules |
| 02/21/2013 | US20130045234 Neutralizing factors as vaccine adjuvants |
| 02/21/2013 | US20130045220 Microvesicle Membrane Protein And Application Thereof |
| 02/21/2013 | US20130045219 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| 02/21/2013 | US20130045218 Fc receptor binding proteins |
| 02/21/2013 | US20130045213 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity |
| 02/21/2013 | US20130045212 Biological Materials and Uses Thereof |
| 02/21/2013 | US20130045210 Pharmaceutical composition for treating and/or preventing cancer |
| 02/21/2013 | US20130045209 WNT-Binding Agents and Uses Thereof |
| 02/21/2013 | US20130045208 Methods for the Treatment of an Infectious Bacterial Disease with an Anti-Lactone or Lactone Derived Signal Molecules Antibody |
| 02/21/2013 | US20130045207 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
| 02/21/2013 | US20130045206 Antibodies directed against the transferrin receptor and uses thereof for immunotherapy of iron-dependent tumours |
| 02/21/2013 | US20130045202 Anti-pd-l1 antibodies and articles of manufacture |
| 02/21/2013 | US20130045180 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2013 | DE102010054767B4 Verfahren zur Trennung, Aufkonzentration und/oder Reinigung von (Blut)Plasmaprotein, Viren oder Virenbestandteilen A process for the separation, concentration and / or purification of (blood) plasma protein, viruses or virus components |
| 02/21/2013 | CA2846240A1 Antibodies that bind integrin alpha-v beta-8 |
| 02/21/2013 | CA2845536A1 Anti-b7-h4 antibodies and their uses |
| 02/21/2013 | CA2845391A1 Soluble polypeptides |
| 02/21/2013 | CA2845029A1 Modified proteins and peptides |
| 02/21/2013 | CA2844674A1 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 02/21/2013 | CA2844289A1 Anti-fzd10 monoclonal antibodies and methods for their use |
| 02/21/2013 | CA2842481A1 Inhibition of angiogenesis in refractory tumors |
| 02/21/2013 | CA2842375A1 Neuregulin antibodies and uses thereof |
| 02/21/2013 | CA2841875A1 Combination therapy with an anti - cd19 antibody and a nitrogen mustard |
| 02/21/2013 | CA2841738A1 Combination therapy with an anti - cd19 antibody and a purine analog |
| 02/20/2013 | EP2560002A2 Method for isolating and/or identifying mesenchymal stem cells (MSC) |
| 02/20/2013 | EP2559766A1 Plants modified for reduced cadmium transport, derivative products, and related methods |
| 02/20/2013 | EP2559762A1 Novel anti-hsp90 monoclonal antibody |
| 02/20/2013 | EP2559706A1 Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same |
| 02/20/2013 | EP2559705A2 Anti-activin a antibodies and uses thereof |
| 02/20/2013 | EP2559704A1 Antibody single variable domains against serum albumin |
| 02/20/2013 | EP2559703A1 Antibody single variable domains against serum albumin |
| 02/20/2013 | EP2559702A1 Antibody single variable domains against serum albumin |
| 02/20/2013 | EP2559440A2 A microvesicle membrane protein and application thereof |
| 02/20/2013 | EP2558591A1 Method for the selection of a long-term producing cell |
| 02/20/2013 | EP2558503A1 Compositions and methods for brain delivery of analgesic peptides |
| 02/20/2013 | EP2558501A1 Monoclonal antibodies against her2 antigens, and uses therefor |
| 02/20/2013 | EP2558500A1 Proteins that bind pi16 and uses thereof |
| 02/20/2013 | EP2558499A2 Anti-vla-4 antibodies |
| 02/20/2013 | EP2558498A2 Antibodies that bind human cd27 and uses thereof |
| 02/20/2013 | EP2558497A2 Human fgf receptor and beta-klotho binding proteins |
| 02/20/2013 | EP2558496A1 Anti-polyubiquitin antibodies and methods of use |
| 02/20/2013 | EP2558495A1 Trail r2-specific multimeric scaffolds |
| 02/20/2013 | EP2558494A2 Amyloid-beta binding proteins |
| 02/20/2013 | EP2558493A2 Antibodies for the treatment of clostridium difficile-associated infection and disease |
| 02/20/2013 | EP2558492A1 Immunoglobulin aggregate removal |
| 02/20/2013 | EP2558490A1 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors |
| 02/20/2013 | EP2558487A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease |
| 02/20/2013 | EP2558125A2 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity |
| 02/20/2013 | EP2558123A2 Methods and compositions for inhibition of treg cells |
| 02/20/2013 | EP2558122A1 Combination treatment with vegf-c antagonists |
| 02/20/2013 | EP2558121A2 Epha3 antibodies for the treatment of multiple myeloma |
| 02/20/2013 | CN102939538A Diagnostic method for the detection of cells ex vivo |
| 02/20/2013 | CN102939306A Humanized anti cxcr4 antibodies for the treatment of cancer |
| 02/20/2013 | CN102939305A Antibodies to cd122 |
| 02/20/2013 | CN102939303A Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 02/20/2013 | CN102939111A Process for preparing an immunoglobulin composition |
| 02/20/2013 | CN102939107A Antibody preparations |
| 02/20/2013 | CN102939004A Specific delivery of agrochemicals |
| 02/20/2013 | CN102936604A Human hcrcn81 pronucleus recombinant plasmid, protein and rabbit anti-human polyclonal antibody expressed by same and application |
| 02/20/2013 | CN102936598A Coding gene of anti-Cry1Ac toxin single-chain variable fragments (scFv) and immuno-polymerase chain reaction (PCR) detection method |
| 02/20/2013 | CN102936584A Semicarbazide derivative monoclonal antibody and applications thereof |
| 02/20/2013 | CN102936583A Furaltadone metabolite derivative monoclonal antibody and applications thereof |
| 02/20/2013 | CN102936582A Furazolidone metabolite derivative monoclonal antibody and applications thereof |
| 02/20/2013 | CN102936287A Antibody capable of binding specifically to A beta-oligomer, and use thereof |
| 02/20/2013 | CN102936286A Anti-anthrax PA antigen monoclonal antibody and applications thereof |
| 02/20/2013 | CN102936285A Antibody for preventing and treating fish Edwardsiellaictaluri disease, preparation method and applications thereof |
| 02/20/2013 | CN102936284A 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use |
| 02/20/2013 | CN102936283A Anti-human CD146 monoclonal antibodies, compositions containing anti-human CD146 monoclonal antibodies, and soluble CD146 detection method |
| 02/20/2013 | CN102154217B Recombinant chicken osteocalcin maturation protein monoclonal antibody and application thereof |
| 02/20/2013 | CN101573384B Antibodies and immunoconjugates and uses therefor |
| 02/19/2013 | US8378082 Anti-CD86 antibody |
| 02/19/2013 | US8378081 Antibodies that specifically bind to Aβ oligomers and uses thereof |
| 02/19/2013 | US8378080 Neuropilin antagonists |
| 02/19/2013 | US8378079 Antibody to human zcyto-10 polypeptide |
| 02/19/2013 | US8378078 Diagnosis of Whipple's disease |
| 02/19/2013 | US8378073 Process for attaching effector molecules to proteins |
| 02/19/2013 | US8378071 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 02/19/2013 | US8378064 Hydrophilic polymers as medical lubricants and gels |
| 02/19/2013 | US8377690 Cells and methods for producing blocking antibodies to human RANKL |
| 02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
| 02/19/2013 | US8377477 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
| 02/19/2013 | US8377444 Therapeutic agent or preventive agent for osteoarthritis |
| 02/19/2013 | US8377443 Antibodies to matrix metalloproteinase 9 |
| 02/19/2013 | US8377440 Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases |
| 02/19/2013 | US8377439 Antagonist antibodies against EPHB3 |
| 02/19/2013 | US8377438 Methods of antagonizing signal transduction in spinal cord cells |
| 02/19/2013 | US8377435 Antibody induced cell membrane wounding |
| 02/19/2013 | CA2587494C Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 02/19/2013 | CA2550489C Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 02/19/2013 | CA2497279C Mutant forms of meningococcal adp-ribosylating toxin |
| 02/19/2013 | CA2487137C Tumour-associated peptides that bind to mhc molecules |
| 02/19/2013 | CA2485120C Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
| 02/19/2013 | CA2443088C Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
| 02/19/2013 | CA2406236C Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
| 02/14/2013 | WO2013023162A2 Anti-muc1 antibodies for cancer diagnostics |
| 02/14/2013 | WO2013023096A1 Bone fusion device, system and method |